BROWNSTEIN HYATT FARBER SCHRECK, LLP

Lobbying for FERRING PHARMACEUTICALS INC. · biopharmaceutical company

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · New Jersey · House · Senate · $50,000.00 income · posted Oct 17, 2025

Lobbying activity 3

Health Issues

Issues related to microbiome, oncology, & fertility Issues related to formulary tier status Drug pricing policy Healthcare policy in the NDAA Pharmaceutical tariffs

Veterans

Issues related to veteran's care and veteran's reproductive care

Trade (domestic/foreign)

Issues related to pharmaceutical tariffs

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.